| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028271183 |
| P356 | DOI | 10.1186/S12944-015-0162-7 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12944-015-0162-7 |
| P932 | PMC publication ID | 4678523 |
| P698 | PubMed publication ID | 26666303 |
| P5875 | ResearchGate publication ID | 287157727 |
| P50 | author | Jan Erik Nordrehaug | Q64019502 |
| P2093 | author name string | Inge Bruheim | |
| Bodil Bjørndal | |||
| Pavol Bohov | |||
| Rolf K Berge | |||
| Asbjørn Svardal | |||
| Marie S Ramsvik | |||
| Espen Rostrup | |||
| P2860 | cites work | Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil | Q21245691 |
| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 | ||
| Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk | Q24603491 | ||
| Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis | Q24629045 | ||
| Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers | Q24634434 | ||
| The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis | Q26852020 | ||
| Krill products: an overview of animal studies | Q28081951 | ||
| A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels | Q28219488 | ||
| Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trial | Q28260672 | ||
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
| Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study | Q28287744 | ||
| Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice | Q33613837 | ||
| Phospholipids from herring roe improve plasma lipids and glucose tolerance in healthy, young adults | Q33684099 | ||
| Concentrations of choline-containing compounds and betaine in common foods | Q34194751 | ||
| Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity | Q34228522 | ||
| Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. | Q34275370 | ||
| Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis | Q34299136 | ||
| Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis | Q34308961 | ||
| Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults | Q34493093 | ||
| N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials | Q34521626 | ||
| n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases | Q34569101 | ||
| HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events | Q34693837 | ||
| Fish oil and the pan-PPAR agonist tetradecylthioacetic acid affect the amino acid and carnitine metabolism in rats | Q34796255 | ||
| Carotenoids: potential allies of cardiovascular health? | Q35061844 | ||
| Omega-3 fatty acids and inflammation | Q35918798 | ||
| A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats | Q36096546 | ||
| Betaine: a key modulator of one-carbon metabolism and homocysteine status | Q36273334 | ||
| The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans | Q36395996 | ||
| Coronary heart disease: seven dietary factors | Q36524342 | ||
| Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. | Q37308117 | ||
| Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects | Q38026944 | ||
| Dietary intake and food sources of choline in European populations. | Q40481541 | ||
| Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans | Q40920965 | ||
| Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. | Q41030418 | ||
| Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study | Q42546469 | ||
| Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. | Q42581553 | ||
| Disturbed carnitine regulation in chronic heart failure--increased plasma levels of palmitoyl-carnitine are associated with poor prognosis | Q43613617 | ||
| Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. | Q44211852 | ||
| Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels | Q44427435 | ||
| Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias | Q44604917 | ||
| An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia | Q44759158 | ||
| Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial | Q46750170 | ||
| Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. | Q51322784 | ||
| Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia. | Q51380011 | ||
| Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNFα. | Q51403862 | ||
| From alga to omega; have we reached peak (fish) oil? | Q52149532 | ||
| The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. | Q53963640 | ||
| Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline | Q56092268 | ||
| Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats | Q70590580 | ||
| alpha-Linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats | Q72729888 | ||
| The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis | Q72934602 | ||
| Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids | Q73655968 | ||
| Long-chain acylcarnitine induces Ca2+ efflux from the sarcoplasmic reticulum | Q73989903 | ||
| Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia | Q74326628 | ||
| Carnitine metabolism and its regulation in microorganisms and mammals | Q77098412 | ||
| Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α | Q84871649 | ||
| P921 | main subject | fatty acid | Q61476 |
| lipoprotein | Q28350 | ||
| Euphausiacea | Q29498 | ||
| P304 | page(s) | 163 | |
| P577 | publication date | 2015-12-15 | |
| P1433 | published in | Lipids in Health and Disease | Q15756695 |
| P1476 | title | Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study | |
| P478 | volume | 14 |
| Q38741861 | Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism |
| Q91952950 | Effects of a nutritional supplement in dogs affected by osteoarthritis |
| Q49166092 | Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial. |
| Q39441530 | Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials |
| Q51744150 | Modulation of miRNA expression in aged rat hippocampus by buttermilk and krill oil. |
| Q90020289 | Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation |
Search more.